When Covid-19 struck, immunologists hit the ground running, and haven’t stopped since. But the effort paid off, writes a scientist who worked on the Oxford clinical trials
From an early age, I was fascinated with the natural world, and in particular how living things work. For me, the interaction between organisms, such as that between a host and a pathogen, is fascinating. I have always been interested in translational research – how can what I am doing at the bench have an impact on the health of the general public?
This sentiment has never been more relevant than now. In the time of a pandemic, the rolling out of vaccines that can prevent disease is a public health intervention which will benefit so many lives.
